» Articles » PMID: 19151012

Discordance Between Microneurographic and Heart-rate Spectral Indices of Sympathetic Activity in Pulmonary Arterial Hypertension

Overview
Journal Heart
Date 2009 Jan 20
PMID 19151012
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To determine, in patients with pulmonary arterial hypertension (PAH), whether there is a relationship: (1) between sympathetic nerve firing rate and spectral indices of sympathetic neural heart rate modulation; and (2) between heart rate variability (HRV) and right atrial pressure, a stimulus to sinoatrial node stretch.

Design: Characterisation of patients and healthy controls.

Setting: Teaching hospital-based study.

Patients: 9 PAH patients without elevated pulmonary capillary wedge pressure and nine age-matched control subjects.

Interventions: Heart rate (HR) and muscle sympathetic nerve activity (MSNA) were recorded during 10 min of supine rest in both PAH patients studied after right heart catheterisation, and healthy volunteers. Coarse-graining spectral analysis determined HR spectral power.

Main Outcome Measures: (1) Low-frequency (PL) spectral component of HRV; (2) MSNA burst frequency; and in PAH patients: (3) right atrial pressure.

Results: MSNA burst frequency was higher in PAH patients (48 (24) and 29 (11) bursts/min, respectively; mean (SD); p = 0.05), whereas total power (p = 0.01), its fractal (p<0.01) and harmonic (p = 0.04) components, and PL (p = 0.01) were all reduced. PL related inversely to both MSNA burst frequency (r = -0.86, p = 0.005) and right atrial systolic pressure (r = -0.77, p = 0.04).

Conclusions: Thus, in PAH (as in patients with left ventricular systolic dysfunction) loss of PL relates inversely to gain in MSNA burst frequency. Diminished sympathetic neural heart rate modulation and increased right atrial stretch may combine to attenuate HRV, an adverse prognostic marker.

Citing Articles

Heart rate variability in pulmonary vascular disease at altitude: a randomised trial.

Herzig J, Ulrich S, Schneider S, Muller J, Lichtblau M, Ulrich T ERJ Open Res. 2024; 10(5).

PMID: 39469267 PMC: 11514194. DOI: 10.1183/23120541.00235-2024.


Effects of Acute Hypoxia on Heart Rate Variability in Patients with Pulmonary Vascular Disease.

Meszaros M, Schneider S, Mayer L, Lichtblau M, Pengo M, Berlier C J Clin Med. 2023; 12(5).

PMID: 36902567 PMC: 10003175. DOI: 10.3390/jcm12051782.


Effects of exercise training on heart rate variability in children and adolescents with pulmonary arterial hypertension: a pilot study.

Siaplaouras J, Frerix M, Apitz A, Zoller D, Apitz C Cardiovasc Diagn Ther. 2021; 11(4):1028-1036.

PMID: 34527528 PMC: 8410481. DOI: 10.21037/cdt-20-263.


Ventilatory efficiency in pulmonary vascular diseases.

Weatherald J, Philipenko B, Montani D, Laveneziana P Eur Respir Rev. 2021; 30(161).

PMID: 34289981 PMC: 9488923. DOI: 10.1183/16000617.0214-2020.


Neurohormonal modulation in pulmonary arterial hypertension.

Peters E, Bogaard H, Vonk Noordegraaf A, de Man F Eur Respir J. 2021; 58(4).

PMID: 33766951 PMC: 8551560. DOI: 10.1183/13993003.04633-2020.